SCHEMBL717088

SCHEMBL717088

CCn1nc(C(CN2CCCC2)N2CCCC2)cc1N

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
RPS6KB1 P23443 7/20 0.32
HRH3 Q9Y5N1 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17045358 0.70 ADORA2A (0.39) HRH3
SCHEMBL691064 0.70 HRH3 (0.48) HRH3
SCHEMBL583517 0.61
SCHEMBL11691084 0.61 ADORA2A (0.45) HRH3
SCHEMBL23608703 0.60
SCHEMBL17045632 0.60 NPC1 (0.46) HRH3
SCHEMBL1292978 0.59 ADORA2A (0.42)
SCHEMBL14662929 0.59 SMN1; SMN2 (0.41)
SCHEMBL3843249 0.57 KDM4E (0.46)
SCHEMBL690635 0.56 ADORA2A (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2421537-A1 PYRAZOLYLAMINOPYRIDINES AS INHIBITORS OF FAK GlaxoSmithKline LLC (US) 2012-02-29 EP disclosed
WO-2010062578-A1 PYRAZOLYLAMINOPYRIDINES AS INHIBITORS OF FAK GLAXOSMITHKLINE LLC (US) 2010-06-03 WO disclosed